1) multidrug resistance-associated protein
多药耐药相关蛋白
1.
Detection of multidrug resistance-associated proteins MRP2,MRP3,and MRP5 mRNA expressions in hepatocarcinoma cells using SYBR real-time PCR;
实时荧光定量PCR检测肝癌细胞多药耐药相关蛋白MRP2、MRP3及MRP5 mRNA的表达
2.
Expression of P-glycoprotein and multidrug resistance-associated protein in esophageal and cardiac carcinoma tissue;
食管、贲门癌组织中P-糖蛋白与多药耐药相关蛋白的表达
3.
Expression of multidrug resistance-associated protein 1,glutathione S transferase π and DNA topoiso meraseⅡin osteosarcoma;
多药耐药相关蛋白1、谷胱甘肽S转移酶和DNA拓扑酶Ⅱ在骨肉瘤中的表达
2) Multidrug resistance associated protein
多药耐药相关蛋白
1.
Objective To study the expressions of P glycoprotein (P gp) and multidrug resistance associated protein (MRP) in orbital rhabdomyosarcoma and its clinical significances.
目的 研究P 糖蛋白(P gp)、多药耐药相关蛋白 (MRP)在眼眶横纹肌肉瘤中的表达及临床意义。
2.
Objective To investigate expression and clinical significance of multidrug resistance protein P-glycoprotein(P-gp)and multidrug resistance associated protein(MRP) in thyroid carcinoma.
目的 探讨多药耐药相关蛋白 (MRP)和P 糖蛋白 (P gp)在甲状腺癌中的表达及临床意义。
3.
Objective: This paper was to explore the relationships between expression of multidrug resistance associated protein (MRP) and clinicopathological parameters and prognosis.
目的 :研究非小细胞肺癌中多药耐药相关蛋白 (MRP)的表达同临床病理特征和病人预后生存期的关系。
3) MRP
多药耐药相关蛋白
1.
Effect of Arsenic Tioxide on MRP Expression in A549/R Cell Line of Human Lung Cancer;
三氧化二砷对人肺腺癌A549/R细胞多药耐药相关蛋白表达的影响
2.
Recently,researches are focussed on the MDR,including P-glycoprotein(Pgp),multidrug resistance-associated protein(MRP),lung resistance-asspcoated protein(LRP),topoisomerase II(TopoII)and breast cancer resistance protein(BCRP).
目前,P-糖蛋白(P-glycoprotein,Pgp)、多药耐药相关蛋白(multidrug resistance-associated protein,MRP)、肺耐药相关蛋白(lung re-sistance-associated protein,LRP)、拓扑异构酶II(topoisomeraseII,TopoII)及乳腺癌耐药蛋白(breast cancer resist-ance protein,BCRP),已成为人们研究的热点。
3.
Objective To investigate the expression of glucose transporter1(GLUT1),multidrug resistance related protein(MRP) and glutathione S-transferase pi(GST-π)in lung cancer.
目的探讨肺癌组织中糖转运蛋白1(glucose transporter1,GLUT1)、多药耐药相关蛋白(multi-drug resistance related protein,MRP)和谷胱甘肽S转移酶-π(glutathione S-transferasepi,GST-π)的表达及其相关性。
4) Multidrug resistance associated protein (MRP)
多药耐药相关蛋白
1.
BACKGROUND &OBJECTIVE: Multidrug resistance associated protein (MRP),glutathione S transferase π(GST π),topoisomeraseⅡα(TopoⅡα)and lung resistance protein (LRP) play important roles in the multidrug resistance(MDR)of tumor chemotherapy.
背景与目的:多药耐药相关蛋白(multidrugresistance-associatedprotein,MRP)、肺耐药蛋白(lungresistanceprotein,LRP)、谷胱甘肽转移酶(glutathione-S-transferase-π,GST-π)和拓扑异构酶Ⅱα(topoisomeraseⅡα,TopoⅡα)均在多药耐药中发挥重要作用。
5) Multidrug resistance-associated protein
多耐药相关蛋白
1.
Objective To investigate the relationship between membrane protein MRP3 (multidrug resistance-associated protein 3) and nuclear receptor Lrh-1 (liver receptor homologue-1) in bile duct ligated (BDL) rat liver.
目的通过建立梗阻性黄疸动物模型,在蛋白水平观察多耐药相关蛋白MRP3(multidrug resistance-associated protein3,MRP3)和核受体Lrh-1(liver receptor homologue-1)表达变化并分析二者之间的关系。
6) Multidrug resistance-associated proteins
多药耐药相关蛋白类
补充资料:醒药
1.醒酒的药。比喻警醒世俗的佛教教义。
说明:补充资料仅用于学习参考,请勿用于其它任何用途。
参考词条